COLL
Collegium Pharmaceutical, Inc.
$27.11
-1.56%
2026-08-21
About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Key Fundamentals
P/E Ratio
22.23
Forward P/E
4.05
EPS (TTM)
$1.27
ROE
17.6%
Revenue Growth (YoY)
6.3%
Profit Margin
5.9%
Debt/Equity
390.46
Price/Book
2.94
Beta
0.76
Market Cap
$915.6M
Avg Volume (10D)
993K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$38.49
60D Low
$25.47
Avg Volume
525K
Latest Close
$27.11
Get breakout alerts for COLL
Sign up for Breakout Scanner to receive daily notifications when COLL triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Collegium Pharmaceutical, Inc. (COLL) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors COLL daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. COLL operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.